2008 - Intensive insulin therapy improved glycemic control more than oral hypoglycemic agents in newly diagnosed type 2 diabetes

Corbett Jr., Eugene C.
September 2008
ACP Journal Club;9/16/2008, Vol. 149 Issue 3, p3
Academic Journal
The article provides an answer to the question whether intensive insulin therapy improves glycemic control and remission rates more than oral hypoglycemic agents in patients suffering from newly diagnosed type 2 diabetes mellitus.


Related Articles

  • Exogenous insulin increased risk for complications, mortality in type 2 diabetes.  // Endocrine Today;Mar2013, Vol. 11 Issue 3, p24 

    The article reports on a study which found that exogenous insulin therapy is linked to an increased risk for diabetes-related complications, cancer and all-cause mortality among patients with type 2 diabetes.

  • Basal insulin therapy in type 2 diabetes: 28-week comparison of insulin glargine (HOE 901) and NPH insulin. Rosenstock, Julio; Schwartz, Sherwyn L.; Clark Jr., Charles M.; Park, Glen D.; Donley, David W.; Edwards, Mike B.; Rosenstock, J; Schwartz, S L; Clark, C M Jr; Park, G D; Donley, D W; Edwards, M B // Diabetes Care;Apr2001, Vol. 24 Issue 4, p631 

    Objective: To determine the safety and efficacy of the long-acting analog insulin glargine compared with NPH insulin in patients with type 2 diabetes who were previously treated with insulin alone.Research Design and Methods: A total of 518 subjects with type 2 diabetes...

  • Insulin.  // Reactions Weekly;8/7/2010, Issue 1313, p27 

    The article describes the case of a 48-year-old man who experienced two cutaneous amyloid tumors while being treated with recombinant human insulin for type 2 diabetes, referencing a study published in the March 2010 issue of the "Netherlands Journal of Medicine."

  • Mix It Up.  // Diabetes Forecast;Jan/Feb2016, Vol. 69 Issue 1, p15 

    The article offers suggestions for taking NPH ("N") intermediate-acting insulin and mentions similar results among type 2 diabetes patients after using NPH vials.

  • Insulin detemir.  // Reactions Weekly;5/15/2010, Issue 1301, p30 

    The article describes the case of a man who developed allergic skin reactions while receiving treatment with insulin detemir for type 2 diabetes mellitus.

  • A comparative study of insulin lispro and human regular insulin in patients with type 2 diabetes mellitus and secondary failure of oral hypoglycemic agents.  // Clinical & Investigative Medicine;Dec2001, Vol. 24 Issue 6, p292 

    Presents information on a study which compared the effects of insulin lispro and human regular insulin on glycemic control, daily blood glucose profiles and rates of hypoglycemia in patients with type 2 diabetes mellitus after failure to respond to sulfonylurea drugs. Research design and...

  • Erratum.  // Diabetes Care;Dec2013, Vol. 36 Issue 12, p4172 

    A correction to the article "Combining Incretin-Based Therapies With Insulin: Realizing the Potential in Type 2 Diabetes" that was published in the journal in 2013 is presented.

  • Insulin plus a sulfonylurea agent for treating type 2 diabetes. Peters, Anne L.; Peters, A L; Davidson, M B // Annals of Internal Medicine;7/1/91, Vol. 115 Issue 1, p45 

    Purpose: To review the recent literature on the efficacy of combined insulin and sulfonylurea therapy in patients with type 2 diabetes.Data Sources: Pertinent articles were obtained through an English-language MEDLINE search from 1979 to 1990 and from the references of...

  • Statins delay initiation of insulin in type 2 diabetes.  // Geriatrics;Aug2002, Vol. 57 Issue 8, p35 

    Suggests that use of statins may delay the initiation of insulin therapy in patients with type 2 diabetes, according to a study presented at the annual meeting of the American Diabetes Association in June 2002 in San Francisco, California. Mechanism of action; Methodology; Interpretation of...

  • DURABLE trial: Twice-daily insulin lispro mix improved glycemic control. Foster, Melissa; Kalvaitis, Katie; McKnight, Whitney // Endocrine Today;Apr2011, Vol. 9 Issue 4, p48 

    The article discusses research being done on the role of earlier insulin initiation in improving glycemic control in patients with type 2 diabetes, referencing a study by J. B. Buse et al, published in a 2011 issue of "Diabetes Care."


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics